$ADHD Release Second Quarter 2015 Financial Results

0
1042

Alcobra Ltd. to Release Second Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on August 13

 Alcobra Ltd. (ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome (FXS), today announced that it will report its financial results for the second quarter ended June 30, 2015 before the market open, and will host a corporate update conference call and webcast on Thursday, August 13 at 8:30 am Eastern Time.

Conference Call & Webcast
Thursday, August 13th @ 8:30am Eastern Time/5:30am Pacific Time
Domestic: 855-469-0611
International: 484-756-4341
Passcode: 82123051
Webcast: http://www.alcobra-pharma.com/events.cfm
Replays available through August 27, 2015
Domestic: 855-859-2056
International: 404-537-3406
Passcode: 82123051

About Alcobra

Alcobra Ltd. is an emerging pharmaceutical company primarily focused on the development and commercialization of a proprietary drug candidate, MDX, to treat cognitive disorders including ADHD and Fragile X Syndrome. For more information please visit the Company’s website,www.alcobra-pharma.com, the content of which is not incorporated herein by reference.

Contact:
U.S. Investor Contact
LifeSci Advisors, LLC
Michael Rice
646-597-6979
[email protected]
Media Inquiries
Sam Brown, Inc.
Mike Beyer
773-463-4211
[email protected]
Israel Investor Contact
Alcobra Investor Relations
Debbie Kaye
+972-72 2204661
[email protected]

LEAVE A REPLY

Please enter your comment!
Please enter your name here